[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__RiskMitigation_4470 

# __Use of specific medicines__

## Property: has_MitigationPrinciple

Repurposing existing medicines such as anti-bacterial, antimalarial, and antiviral drugs, as well as protease inhibitors and corticosteroids, for the treatment of COVID-19. These medicines are used to reduce the severity of symptoms and prevent complications in infected individuals.

## Risks possibly mitigated by this Mitigation


## Property: has_MitigationSource

* [Nurture to nature via COVID-19, a self-regenerating environmental strategy of environment in global context](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_44.md)

## This Mitigation is enabled by the following technologies

* [Antiviral](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3128.md)
* [Antimalarial](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3127.md)
* [Anti-bacterial](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3126.md)
* [Protease inhibitors](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3129.md)
* [Corticosteroids](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3130.md)

